Specificity, diversity, and convergence in VEGF and TNF-α signaling events leading to tissue factor upregulation via EGR-1 in endothelial cells

FASEB Journal

Volumn 15, Issue 1, 2001, Pages 230-242

  Mechtcheriakova, D ^a   Schabbauer, G ^a   Lucerna, M ^a   Clauss, M ^a   De Martin, R ^a   Binder, B R ^a   Hofer, E ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenic growth factors; Endothelium; Inflammatory cytokines; MAP kinases; Tissue factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE INDUCTION; GENETIC REGULATION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; INFLAMMATORY CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TARGET CELL; VIRUS EXPRESSION;

CELLS, CULTURED; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FLAVONOIDS; GENES, DOMINANT; HUMANS; I-KAPPA B KINASE; IMMEDIATE-EARLY PROTEINS; LYMPHOKINES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR CROSS-TALK; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SUBSTRATE SPECIFICITY; TETRADECANOYLPHORBOL ACETATE; THROMBOPLASTIN; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035174972     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0247com     Document Type: Article

References (74)

1. The structural biology of expression and function of tissue factor
2. Structural biology of tissue factor, the initiator of thrombogenesis in vivo
3. Role of tissue factor in embryonic blood vessel development
4. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease
5. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice
6. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280
7. Endothelial cells in physiology and in the pathophysiology of vascular disorders
8. Regulation of the tissue factor gene
9. Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: Functional analysis of the tumor necrosis factor receptors
10. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors
11. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1
12. Signalling by receptor tyrosine kinases
13. Jaks. STATs, cytokine signal transduction, and immunoregulation: Are we there yet?
14. Cytokine receptors and signal transduction
15. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation
16. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
17. Primary response genes induced by growth factors and tumor promoters
18. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
19. Function and activation of NF-kappa B in the immune system
20. IkappaB kinase: Beginning, not the end
21. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation
22. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB
23. Regulation of the Egr-1 gene by tumor necrosis factor and interferons in primary human fibroblasts
24. Transcriptional regulation of vascular cell proteins
25. New insights into the control of MAP kinase pathways
26. Dissection of protein kinase cascades that mediate cellular response to cytokines and cellular stress
27. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
28. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
29. Adenovirus-mediated expression of green fluorescent protein
30. Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein
31. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
32. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
33. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites
34. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
35. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1
36. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase)
37. Protein kinase C-dependent and -independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2
38. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976
39. Differential inhibition of cytosolic and membrane-derived protein kinase C
40. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells
41. Activation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways
42. Identification and characterization of an IkappaB kinase
43. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1
44. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway
45. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1
46. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf
47. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs
48. MEK kinase is involved in tumor necrosis factor alpha-induced NF-kappaB activation and degradation of IkappaB-alpha
49. Raf-1 activates MAP kinase-kinase
50. Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation
51. Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure
52. Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers
53. Multiple intracellular pathways induce expression of a zinc-finger encoding gene (EGR1): Relationship to activation of the Na/H exchanger
54. Hypoxia-associated induction of early growth response-1 gene expression
55. Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis
56. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by cerarnide and arachidonic acid
57. Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta
58. Activation of IkappaB kinase beta by protein kinase C isoforms
59. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
60. PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation
61. Protein kinase Cdelta mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells
62. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: A role for tissue factor gene expression
63. Signaling via vascular endothelial growth factor receptors
64. The biology of vascular endothelial growth factor
65. A novel vascular endothelial growth factor encoded by Orfvirus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1(Flt-1) receptor tyrosine kinases
66. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis
67. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
68. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
69. The transcriptional corepressor NAB2 inhibits NGF-induced differentiation of PC12 cells
70. Molecular physiology of granulocytemacrophage colony-stimulating factor
71. Unique pathway of IL-3-driven hemopoietic differentiation
72. Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase
73. Granulocyte-macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB binding site in the human egr-1 promoter
74. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site